Under a new proposal from Switzerland’s Federal Council (the collective head of state of the nation), medical cannabis will be fully legalized, allowing patients to directly get approval from their doctor. The proposal would “lift the ban on the circulation of medical cannabis in the law on narcotics,” making the “cultivation, processing and trade of medical cannabis” possible within the framework of the control system provided by Swissmedic, the country’s drug regulatory agency.
Reuters reported this week that the Swiss government aims to make it easier for patients to get medical marijuana, proposing on Wednesday to allow prescriptions for cannabis to treat people suffering from cancer or other serious conditions.
The proposal, separate from a Swiss government push to allow some cities to experiment with recreational marijuana, would replace the current system, in which those seeking medical cannabis must apply for an exception from the Federal Health Office to get what is otherwise an illegal drug.
Marijuana is sometimes used to help cancer patients manage chronic pain, to help boost their appetites, and to reduce spasticity associated with multiple sclerosis.
Switzerland has been relatively progressive on cannabis, including the legalization of cannabis with no more than 1% THC. However, the Swiss medical program has been restrictive, forcing patients to get special authorization from the Federal Office of Public Health.
Even with that approval, patients could only get cannabis tinctures and oil, not flower, from a very limited number of dispensaries. Currently, only about 3,000 authorizations have been granted.
In contrast, non-medical cannabis continues to be banned. The cannabis-based treatments that can be prescribed in Switzerland are either medicines authorized by Swissmedic, or master preparations developed in pharmacy, and are usually taken orally.
Medical cannabis is used to relieve chronic pain and stimulate the appetite of patients suffering from cancer. It is also used to reduce spasticity in multiple sclerosis. Switzerland cited increased use of medical marijuana in the treatment of a variety of conditions is driving the narrative.
A grace period will run until mid-October to monitor how it is progressing. Elsewhere in the world medical marijuana is booming. Portugal has just released a bill to legalise marijuana-based medicines, following on from Italy, Germany and Canada. Ireland too. This is a massive step forward for the Swiss cannabis community. Watch this space.
The line is old and never made sense in the first place, but politician after politician like to extol the fear that if they legalize cannabis, everyone will become a pothead. As it turns out, study after study say the opposite, that legalizations don’t increase cannabis use, particularly in younger populations. Take a look. Yet […]
The post Another Study Says Legalizations Don’t Increase Cannabis Use appeared first on Cannadelics.
All eyes are on Switzerland as the country makes big moves to start its own cannabis industry. The country announced plans for a recreational measure last year, and now Switzerland is introducing a wide-reaching medical program that goes far beyond its previous limits. Switzerland is on a rampage, both widening its medical cannabis program, and […]
The post Switzerland Implements Wide-Reaching Medical Cannabis Program appeared first on Cannadelics.
The psychedelics industry is gearing up for a massive debut, and opinions on the compounds are changing for the better. How popular are psychedelics in America right now? New survey results show that these compounds are not unknown to the American public, and that close to 30% of respondents, have already tried them. With the […]
The post How Popular Are Psychedelics In America? Survey Says ~30% Have Tried appeared first on Cannadelics.
Summer Savings Sale